In this study, the expression of PPARα was significantly reduced in NAFL and NASH mice compared to the NC group; however, Ganweikang tablet partially reversed this effect (Figure 7E and Supplementary Figure S1E), suggesting that Ganweikang tablet could increase FAO levels in the liver of NAFLD model mice. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.